Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LABP

Landos Biopharma (LABP) Stock Price, News & Analysis

Landos Biopharma logo

About Landos Biopharma Stock (NASDAQ:LABP)

Advanced Chart

Key Stats

Today's Range
$22.75
$22.94
50-Day Range
$21.51
$22.93
52-Week Range
$2.50
$22.94
Volume
50,800 shs
Average Volume
19,700 shs
Market Capitalization
$71.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LABP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LABP Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
AbbVie Completes Acquisition of Landos Biopharma
See More Headlines

LABP Stock Analysis - Frequently Asked Questions

Landos Biopharma, Inc. (NASDAQ:LABP) issued its quarterly earnings results on Friday, May, 12th. The company reported ($0.90) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.00) by $0.10.

Landos Biopharma shares reverse split on the morning of Friday, May 26th 2023.The 1-10 reverse split was announced on Friday, May 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Landos Biopharma (LABP) raised $101 million in an IPO on Thursday, February 4th 2021. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and SVB Leerink acted as the underwriters for the IPO and Raymond James was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Landos Biopharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), e.l.f. Beauty (ELF), Jabil (JBL) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/12/2023
Today
7/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LABP
CIK
1785345
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-73.00%
Return on Assets
-63.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.43
Quick Ratio
4.43

Sales & Book Value

Annual Sales
$18 million
Price / Sales
3.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.41 per share
Price / Book
3.09

Miscellaneous

Outstanding Shares
3,130,000
Free Float
3,085,000
Market Cap
$71.77 million
Optionable
Not Optionable
Beta
0.14
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:LABP) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners